Samuel Whiting

TPST

Samuel Whiting serves as Chief Medical Officer at Tempest Therapeutics, Inc. (TPST). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$18.1K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$18.1K

Companies Traded

TPST

Active Period

Jan 2022 – Jul 2024

2 total trades

Most Recent

Buy TPST

Jul 3, 2024 · $10.0K

Samuel Whiting's Insider Trading at Tempest Therapeutics, Inc. (TPST)

Buys

2 · $18.1K

Sells

0 · $0.00

Total Shares Bought

6,372

Total Shares Sold

TPST Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 3, 2024	Buy	4,672	$2.13	$10.0K	9,573
Jan 10, 2022	Buy	1,700	$4.80	$8.2K	1,901

Related Insiders

Matthew Angel

director, 10 percent owner, officer: CEO and President

TPSTBuy · Mar 25, 2026

Explore More Insider Trading Data

TPST Insider Trading Activity

View all insider trades at Tempest Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity